Images

Filter by

Table 1 Screening Tools for Assessment of Frailty
Table 1: Screening Tools for Assessment of Frailty
Figure 1 Shared Pathophysiological Mechanisms Between Frailty and Cancer Therapy related Cardiovascular Toxicity
Figure 1: Shared Pathophysiological Mechanisms Between Frailty and Cancer Therapy-related Cardiovascular Toxicity
Figure 1 Receiver Operating Characteristic Curve Comparison of Risk Stratification Scores Modified WHO ZAHARA DEVI and CARPREG II
Figure 1: Receiver Operating Characteristic Curve Comparison of Risk Stratification Scores Modified WHO, ZAHARA, DEVI and CARPREG II
Table 4 Logistic Regression of Determinants of Maternal and Neonatal Adverse Clinical Outcomes
Table 4: Logistic Regression of Determinants of Maternal and Neonatal Adverse Clinical Outcomes
Table 3 Relationship of Various Determinants to Adverse Neonatal Outcomes
Table 3: Relationship of Various Determinants to Adverse Neonatal Outcomes
Table 2 Characteristics of Adverse Neonatal Outcomes
Table 2: Characteristics of Adverse Neonatal Outcomes
Table 1 Characteristics of Adverse Maternal Outcomes
Table 1: Characteristics of Adverse Maternal Outcomes
Figure 1 Simplified Pathophysiology Linking Obesity and Heart Failure
Figure 1: Simplified Pathophysiology Linking Obesity and Heart Failure
Figure 2 Polysomnography Before and After Phrenic Nerve Stimulator Implantation
Figure 2: Polysomnography Before and After Phrenic Nerve Stimulator Implantation
Figure 1 Examples of Phrenic Nerve Stimulator Implants
Figure 1: Examples of Phrenic Nerve Stimulator Implants
Table 2 Randomised Studies of Discontinuation or Reduction of Pharmacological Therapy in Patients with HFimpEF
Table 2: Randomised Studies of Discontinuation or Reduction of Pharmacological Therapy in Patients with HFimpEF
Table 1 Predictors of Reverse Remodelling Occurrence Maintenance and Risk of Relapse
Table 1: Predictors of Reverse Remodelling: Occurrence, Maintenance and Risk of Relapse